Toggle navigation
Home
Search
Services
Blog
Contact
About
Endothelial Antigens Recognized by Allogenic Ctl
Nishimura, Yasuharu
Dana-Farber Cancer Institute, Boston, MA, United States
Search grants from Yasuharu Nishimura
Search grants from Dana-Farber Cancer Institute
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Core B: Health Care and Population Science Core
Cell Penetrating Peptide Inhibitor of FoxM1 in Hepatocellular Carcinoma Treatment
Effects of Glyceryl Trinitrate (GTN) in Patients with Preeclampsia
Marital Gender Roles and Dynamics of Spousal Care
Assessing the impact of a disciplinary Teaching and Learning Center on current and future faculty professional development
Recently added grants:
Multiscale analysis of MyosinA-based motility in Toxoplasma gondii
Epigenetic modulation of the TAZ-CAMTA1 transcriptional program by the Ada2a-containing histone acetyltransferase complex
UNC Geriatric Oncology Training Grant (UNC-GO)
Genetic and genomic determinants of homologous recombination repair deficiency as treatment selection markers for lethal prostate cancer
Identifying Therapeutic Targets for Stage III Melanoma
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
International Research Fellowships (FIC) (F05)
Project #
3F05TW003679-01S1
Application #
3020890
Study Section
(BI)
Project Start
1986-09-01
Project End
Budget Start
1986-09-01
Budget End
1986-12-31
Support Year
1
Fiscal Year
1986
Total Cost
Indirect Cost
Institution
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Related projects
NIH 1986
F05 TW
Endothelial Antigens Recognized by Allogenic Ctl
Nishimura, Yasuharu / Dana-Farber Cancer Institute
NIH 1985
F05 TW
Endothelial Antigens Recognized by Allogenic Ctl
Nishimura, Yasuharu / Dana-Farber Cancer Institute
Comments
Be the first to comment on Yasuharu Nishimura's grant